Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | See Remark | May 03, 2024 | May 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date May 03, 2024 · Filed May 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 345,188 |
Reported balance
After 2024-05-03 transaction · row 1
1 source rowRow 1 · 2024-05-03 · Sale · Disposed 798 · Balance 345,188 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 08, 2020 Filed Jul 10, 2020 20:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 800 | $55.04 | $44,028.80 |
DisclosureSEC source: 0001214659-20-006268 · marketforms-49211.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 515,592 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $54.74 to $55.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 08, 2020 Filed Jul 10, 2020 20:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,309 | $54.15 | $341,656.32 |
DisclosureSEC source: 0001214659-20-006268 · marketforms-49211.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 516,392 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $53.68 to $54.62 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 08, 2020 Filed Jul 10, 2020 20:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 12,734 | $52.97 | $674,531.44 |
DisclosureSEC source: 0001214659-20-006268 · marketforms-49211.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 522,701 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $52.66 to $53.65 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 08, 2020 Filed Jul 10, 2020 20:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,200 | $52.45 | $220,303.86 |
DisclosureSEC source: 0001214659-20-006268 · marketforms-49211.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 535,435 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $51.66 to $52.65 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 08, 2020 Filed Jul 10, 2020 20:15 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 957 | $50.44 | $48,272.90 |
DisclosureSEC source: 0001214659-20-006268 · marketforms-49211.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 539,635 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $50.02 to $50.95 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 16, 2020 Filed Jun 17, 2020 21:18 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 11,000 | $38.75 | $426,203.80 |
DisclosureSEC source: 0001214659-20-005741 · marketforms-49044.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 540,592 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $38.26 to $39.19 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:18 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 300 | $39.36 | $11,808.00 |
DisclosureSEC source: 0001214659-20-005741 · marketforms-49044.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 551,592 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $39.28 to $39.47 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:18 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,122 | $38.89 | $199,185.87 |
DisclosureSEC source: 0001214659-20-005741 · marketforms-49044.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 551,892 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $38.27 to $39.16 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:18 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,341 | $37.79 | $126,256.39 |
DisclosureSEC source: 0001214659-20-005741 · marketforms-49044.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 557,014 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $37.27 to $38.24 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 15, 2020 Filed Jun 17, 2020 21:18 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,237 | $36.82 | $82,356.27 |
DisclosureSEC source: 0001214659-20-005741 · marketforms-49044.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 560,355 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $36.25 to $37.22 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 21:04 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 20,113 | $40.01 | $804,640.68 |
DisclosureSEC source: 0001214659-20-005369 · marketforms-48953.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 562,592 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $40.00 to $40.08 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 21, 2020 Filed May 23, 2020 01:07 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,887 | $40.03 | $195,628.56 |
DisclosureSEC source: 0001214659-20-004968 · marketforms-48852.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 582,705 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $40.00 to $40.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:07 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $39.76 | $26,838.00 |
DisclosureSEC source: 0001214659-20-004968 · marketforms-48852.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 587,592 F4 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:07 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,784 | $40.18 | $152,037.34 |
DisclosureSEC source: 0001214659-20-004968 · marketforms-48852.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 588,267 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $39.98 to $40.66 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| May 20, 2020 Filed May 23, 2020 01:07 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 18,216 | $39.56 | $720,579.42 |
DisclosureSEC source: 0001214659-20-004968 · marketforms-48852.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 592,051 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $38.96 to $39.92 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 20, 2020 Filed Feb 25, 2020 00:01 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $33.13 | $22,362.75 |
DisclosureSEC source: 0001214659-20-001758 · marketforms-47848.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610,358 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| February 20, 2020 Filed Mar 20, 2020 20:35 UTC Amendment | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 766 | $33.13 | $25,377.58 |
DisclosureSEC source: 0001214659-20-002801 · marketforms-48387.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 610,267 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). F2 · shares: The Form 4 originally filed on 2/24/2020 incorrectly reported 675 shares withheld to pay Reporting Person's tax withholding obligation in connection with the vesting of certain RSUs previously granted to the Reporting Person. Read SEC document |
| February 18, 2020 Filed Feb 20, 2020 21:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 11,000 | $30.71 | $337,777.00 |
DisclosureSEC source: 0001214659-20-001629 · marketforms-47796.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 611,033 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $30.31 to $31.28 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 21:57 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,776 | $23.17 | $87,501.25 |
DisclosureSEC source: 0001214659-20-000431 · marketforms-47468.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622,033 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.98 to $23.58 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 16, 2020 Filed Jan 17, 2020 21:57 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,224 | $22.46 | $162,279.94 |
DisclosureSEC source: 0001214659-20-000431 · marketforms-47468.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,809 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.98 to $22.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 21:57 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,198 | $23.87 | $52,472.85 |
DisclosureSEC source: 0001214659-20-000431 · marketforms-47468.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 633,033 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.59 to $24.22 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 21:57 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,802 | $23.01 | $110,479.61 |
DisclosureSEC source: 0001214659-20-000431 · marketforms-47468.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 635,231 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.55 to $23.41 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 21:57 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,000 | $22.03 | $88,116.00 |
DisclosureSEC source: 0001214659-20-000431 · marketforms-47468.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 640,033 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.49 to $22.39 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 17, 2019 Filed Dec 18, 2019 22:56 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 11,000 | $25.63 | $281,908.00 |
DisclosureSEC source: 0001214659-19-007787 · marketforms-46868.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 644,033 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.81 to $26.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 22:56 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 11,000 | $26.69 | $293,568.00 |
DisclosureSEC source: 0001214659-19-007787 · marketforms-46868.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 655,033 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $26.39 to $27.22 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 20, 2019 Filed Nov 21, 2019 23:33 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 2,698 | $22.85 | $61,649.30 |
DisclosureSEC source: 0001214659-19-007341 · marketforms-46377.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 666,033 Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 22:21 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 200 | $21.56 | $4,311.40 |
DisclosureSEC source: 0001209191-19-057258 · doc4.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 668,731 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.55 to $21.64 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 18, 2019 Filed Nov 19, 2019 22:21 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 10,800 | $21.01 | $226,951.20 |
DisclosureSEC source: 0001209191-19-057258 · doc4.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 668,931 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $20.46 to $21.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 22:21 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 11,000 | $21.48 | $236,302.00 |
DisclosureSEC source: 0001209191-19-057258 · doc4.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 679,731 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $21.16 to $21.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 24, 2019 Filed Nov 6, 2019 02:23 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantEmployee Stock Option (right to buy) · Derivative | 39,710 | $0.00 Strike: $23.33 | $0.00 |
DisclosureSEC source: 0001209191-19-055404 · doc4.xml · derivative · entry 2 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,710 Underlying: Common Stock · 39,710 shares Expires 2029-10-23 F2 · derivative.exercise_date: 25% of the shares subject to the option vest and become exercisable on October 24, 2020 and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuing service through each vesting date. Read SEC document |
| October 24, 2019 Filed Nov 6, 2019 02:23 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 9,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-055404 · doc4.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 690,731 F1 · shares: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 25% of the shares subject to the RSU Award vesting on October 24, 2020 and 1/16th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 00:14 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,370 | $24.35 | $130,764.87 |
DisclosureSEC source: 0001209191-19-053540 · doc4.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 681,461 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $24.20 to $24.50 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 16, 2019 Filed Oct 18, 2019 00:14 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,630 | $23.58 | $132,772.29 |
DisclosureSEC source: 0001209191-19-053540 · doc4.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 686,831 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.18 to $24.14 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 00:14 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,304 | $23.67 | $54,528.77 |
DisclosureSEC source: 0001209191-19-053540 · doc4.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 692,461 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $23.64 to $23.72 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| October 15, 2019 Filed Oct 18, 2019 00:14 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 8,696 | $23.27 | $202,312.44 |
DisclosureSEC source: 0001209191-19-053540 · doc4.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694,765 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $22.64 to $23.62 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 17, 2019 Filed Sep 18, 2019 20:17 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,200 | $30.08 | $66,182.60 |
DisclosureSEC source: 0001209191-19-050056 · doc4.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703,461 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $29.99 to $30.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 17, 2019 Filed Sep 18, 2019 20:17 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 8,800 | $29.50 | $259,600.00 |
DisclosureSEC source: 0001209191-19-050056 · doc4.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705,661 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.99 to $29.98 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| September 16, 2019 Filed Sep 18, 2019 20:17 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 11,000 | $30.11 | $331,166.00 |
DisclosureSEC source: 0001209191-19-050056 · doc4.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 714,461 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $29.67 to $30.34 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 22:03 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 3,796 | $28.32 | $107,498.92 |
DisclosureSEC source: 0001209191-19-047633 · doc4.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 725,461 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.18 to $28.60 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 27, 2019 Filed Aug 28, 2019 22:03 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 7,204 | $27.68 | $199,370.70 |
DisclosureSEC source: 0001209191-19-047633 · doc4.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 729,257 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $27.14 to $28.13 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 26, 2019 Filed Aug 28, 2019 22:03 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 513 | $28.47 | $14,602.55 |
DisclosureSEC source: 0001209191-19-047633 · doc4.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 736,461 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.40 to $28.54 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| August 26, 2019 Filed Aug 28, 2019 22:03 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 10,487 | $27.91 | $292,702.66 |
DisclosureSEC source: 0001209191-19-047633 · doc4.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 736,974 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. F2 · shares: Represents the aggregate of sales effected on the same day at different prices. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $27.40 to $28.39 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. F4 · balance_after: Includes shares that were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 22:40 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantEmployee Stock Option (right to buy) · Derivative | 91,004 | $0.00 Strike: $26.66 | $0.00 |
DisclosureSEC source: 0001209191-18-059795 · doc4.xml · derivative · entry 2 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,004 Underlying: Common Stock · 91,004 shares Expires 2028-11-18 F2 · derivative.exercise_date: 12/60th of the shares subject to the option vest and become exercisable on October 31, 2019 and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 22:40 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 39,002 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-059795 · doc4.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 747,332 F1 · shares: Represents a restricted stock unit award (the "RSU Award") that vests in installments, with 12/60th of the shares subject to the RSU Award vesting on November 20, 2019 and 1/20th of the shares subject to the RSU Award vesting on each quarterly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.